{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:11:56Z","timestamp":1779286316903,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHLT Open"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jhlto.2026.100482","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:13:04Z","timestamp":1768291984000},"page":"100482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The looming threat of invasive fungal infections in heart transplant recipients: Will it be the last of us"],"prefix":"10.1016","volume":"12","author":[{"given":"Adam","family":"Lowe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Travis","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5752-9576","authenticated-orcid":false,"given":"Jonathan","family":"Hand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhlto.2026.100482_bib1","doi-asserted-by":"crossref","first-page":"S305","DOI":"10.1016\/j.ajt.2024.01.016","article-title":"OPTN\/SRTR 2022 annual data report: heart","volume":"24","author":"Colvin","year":"2024","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhlto.2026.100482_bib2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.healun.2024.03.004","article-title":"The International Society for Heart and Lung Transplantation (ISHLT): 2024 infection definitions for durable and acute mechanical circulatory support devices","volume":"43","author":"Aslam","year":"2024","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2026.100482_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13714","article-title":"Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients","volume":"23","author":"Yetmar","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.healun.2014.09.036","article-title":"Risk factors for invasive fungal disease in heart transplant recipients","volume":"34","author":"Rabin","year":"2015","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2026.100482_bib5","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/650454","article-title":"Risk factors and outcomes of fungal ventricular-assist device infections","volume":"50","author":"Aslam","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12650","article-title":"Invasive fungal infection after heart transplantation: a 7-year, single-center experience","volume":"19","author":"Echenique","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib8","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13054-018-2023-z","article-title":"Fungal infections in adult patients on extracorporeal life support","volume":"22","author":"Cavayas","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.jhlto.2026.100482_bib10","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1086\/376527","article-title":"Invasive aspergillosis in the setting of cardiac transplantation","volume":"37","author":"Montoya","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib11","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1097\/TP.0000000000003307","article-title":"Recent trends of infectious complications following heart transplantation","volume":"104","author":"Multani","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.jhlto.2026.100482_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13553","article-title":"Endemic fungal infections in solid organ transplant recipients-Guidelines from the American Society of Transplantation infectious disease community of practice","volume":"33","author":"Miller","year":"2019","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhlto.2026.100482_bib13","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/ajt.12691","article-title":"Epidemiology of invasive mold infections in lung transplant recipients","volume":"14","author":"Doligalski","year":"2014","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhlto.2026.100482_bib14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.idc.2018.04.006","article-title":"Mold infections in solid organ transplant recipients","volume":"32","author":"Lemonovich","year":"2018","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jhlto.2026.100482_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae036","article-title":"Clinical characteristics and outcomes of endemic mycoses after solid organ transplantation: a comprehensive review","volume":"11","author":"Abad","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib16","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/01.tp.0000441088.01723.ee","article-title":"Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection","volume":"97","author":"Tissot","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.jhlto.2026.100482_bib17","first-page":"112","article-title":"Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients","volume":"70","author":"Grossi","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jhlto.2026.100482_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13250","article-title":"Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: a population based cohort study","volume":"22","author":"Hosseini-Moghaddam","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1399-3046.2010.01415.x","article-title":"Invasive fungal infections in pediatric heart transplant recipients: incidence, risk factors, and outcomes","volume":"15","author":"Zaoutis","year":"2011","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhlto.2026.100482_bib20","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1086\/509640","article-title":"Candidemia in patients with ventricular assist devices","volume":"44","author":"Shoham","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib21","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3390\/antibiotics10111330","article-title":"Clinically relevant interactions with anti-infectives on intensive care units\u2014a multicenter delphi study","volume":"10","author":"Koeck","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.jhlto.2026.100482_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cpt.583","article-title":"Clinical pharmacogenomics implementation consortium (CPIC) guidelines for CYP2C19 and voriconazole therapy","volume":"102","author":"Moriyama","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhlto.2026.100482_bib23","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/phar.2850","article-title":"Utility of triazole antifungal therapeutic drug monitoring: insights from the society of infectious diseases pharmacists: endorsed by the mycoses study group education and research consortium","volume":"43","author":"McCreary","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jhlto.2026.100482_bib24","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/598327","article-title":"Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents","volume":"48","author":"Bruggeman","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.idc.2015.10.012","article-title":"Antifungal agents: spectrum of activity, pharmacology, and clinical indications","volume":"30","author":"Nett","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jhlto.2026.100482_bib26","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.01458-07","article-title":"Combination echinocandin-polyene treatment of murine mucormycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhlto.2026.100482_bib27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.anl.2011.03.006","article-title":"Successful treatment of rhino-orbital mucormycosis by a new combination therapy with liposomal amphotericin B and micafungin","volume":"39","author":"Ogawa","year":"2012","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jhlto.2026.100482_bib28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/myc.12909","article-title":"Antifungal combinations in mucorales: a microbiological perspective","volume":"62","author":"Schwarz","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.jhlto.2026.100482_bib29","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/504492","article-title":"Pharmacology of systemic antifungal agents","volume":"43","author":"Ashley","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib30","unstructured":"Centers for Disease, C; Prevention. Antibiotic resistance threats in the United States. 2024."},{"key":"10.1016\/j.jhlto.2026.100482_bib31","unstructured":"World Health, O. WHO fungal priority pathogens list to guide research, development, and public health action. 2024."},{"key":"10.1016\/j.jhlto.2026.100482_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13623","article-title":"Candida infections in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Aslam","year":"2019","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhlto.2026.100482_bib33","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1056\/NEJMra2402635","article-title":"Candida auris infections","volume":"391","author":"Lionakis","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2026.100482_bib34","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of america","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.idc.2024.11.003","article-title":"An update on fungal disease outbreaks of public health concern","volume":"39","author":"Smith","year":"2024","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jhlto.2026.100482_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13919","article-title":"Challenges and opportunities in stewardship among solid organ transplant recipients with Candida auris bloodstream infections","volume":"24","author":"Vu","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib37","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2666-5247(24)00039-9","article-title":"Impact of climate change and natural disasters on fungal infections","volume":"5","author":"Seidel","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jhlto.2026.100482_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1399-3062.2011.00658.x","article-title":"A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation","volume":"14","author":"Grim","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib39","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.healun.2016.01.007","article-title":"The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: executive summary","volume":"35","author":"Husain","year":"2016","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2026.100482_bib41","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1093\/infdis\/jiaa394","article-title":"Core recommendations for antifungal stewardship: A statement of the Mycoses Study Group Education and Research Consortium","volume":"222","author":"Johnson","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib42","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.healun.2021.03.024","article-title":"The growing dilemma of legalized cannabis and heart transplantation","volume":"40","author":"Olt","year":"2021","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2026.100482_bib43","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.ajt.2024.02.022","article-title":"Impact of deceased organ donor marijuana use on donor culture positivity and solid organ transplant recipient outcomes","volume":"24","author":"Moore","year":"2024","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhlto.2026.100482_bib44","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/ajt.16178","article-title":"Ten years of donor-derived disease: a report of the Disease Transmission Advisory Committee","volume":"21","author":"Kaul","year":"2021","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhlto.2026.100482_bib45","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/cid\/cix460","article-title":"Donor-derived transmission of Candida auris during lung transplantation","volume":"65","author":"Azar","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib46","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14331","article-title":"Outcomes in solid organ transplant recipients receiving organs from a donor with fusarium solani species complex","volume":"26","author":"Griffin","year":"2024","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15199","article-title":"Donor-derived endemic mycoses after solid organ transplantation: a review of reported cases","volume":"38","author":"Abad","year":"2024","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhlto.2026.100482_bib48","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guidelines for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhlto.2026.100482_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/jof7020127","article-title":"The evolving landscape of fungal diagnostics, current and emerging microbiological approaches","volume":"7","author":"Freeman Weiss","year":"2021","journal-title":"J Fungi"},{"key":"10.1016\/j.jhlto.2026.100482_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01784-20","article-title":"Recognition of diagnostic gaps for laboratory diagnosis of fungal diseases: expert opinion from the fungal diagnostics laboratories consortium (FDLC)","volume":"59","author":"Zhang","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhlto.2026.100482_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.semnuclmed.2022.07.003","article-title":"Imaging of invasive fungal infections-the role of PET\/CT","volume":"52","author":"Ankrah","year":"2023","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.jhlto.2026.100482_bib52","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.healun.2023.11.002","article-title":"18F-FDG PET\/CT in left ventricular assist device infections: in-depth characterization and clinical implications","volume":"43","author":"Devesa","year":"2024","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2026.100482_bib53","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.jhlto.2026.100482_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.732223","article-title":"Antifungal pipeline","volume":"11","author":"McCarty","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jhlto.2026.100482_bib55","unstructured":"NCT03583164. Phase IIb Open-Label Study of F901318 (Olorofim) for the Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium spp., Aspergillus spp., and Other Resistant Fungi in Patients Lacking Suitable Alternative Treatment Options. ClinicalTrials.gov. Updated 2018; accessed\u00a0August 15, 2025."},{"key":"10.1016\/j.jhlto.2026.100482_bib56","first-page":"e01623","article-title":"Phase 1 drug-drug interaction study to assess the effect of CYP3A4 inhibition and pan-CYP induction on the pharmacokinetics and safety of fosmanogepix in healthy participants","volume":"68","author":"Hodges","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhlto.2026.100482_bib57","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/AAC.00291-11","article-title":"In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds","volume":"55","author":"Miyazaki","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhlto.2026.100482_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01795-20","article-title":"Efficacy and pharmacokinetics of Fosmanogepix (APX001) in the treatment of candida endophthalmitis and hematogenous meningoencephalitis in nonneutropenic rabbits","volume":"65","author":"Petraitiene","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhlto.2026.100482_bib59","unstructured":"NCT05421858. A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and\/or Invasive Candidiasis. ClinicalTrials.gov. Updated August 12, 2025. Accessed August 15, 2025."},{"key":"10.1016\/j.jhlto.2026.100482_bib60","unstructured":"Cornelissen\u00a0K,\u00a0Kennedy\u00a0T, Rex\u00a0JH. Tissue distribution of (14C)-olorofim following intravenous dosing in the rat. 31st European Congress of Clinical Microbiology and Infectious Diseases 2021."},{"key":"10.1016\/j.jhlto.2026.100482_bib61","doi-asserted-by":"crossref","first-page":"e01616","DOI":"10.1128\/AAC.01627-16","article-title":"Safety and pharmacokinetics of CD101 IV, a novel echinocandin, in healthy adults","volume":"61","author":"Sandison","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhlto.2026.100482_bib62","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1146\/annurev-micro-041020-111511","article-title":"Harnessing the immune response to fungal pathogens for vaccine development","volume":"76","author":"Rivera","year":"2022","journal-title":"Annu Rev Microbiol"}],"container-title":["JHLT Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133426000030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133426000030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:40:04Z","timestamp":1779284404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950133426000030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":62,"alternative-id":["S2950133426000030"],"URL":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100482","relation":{},"ISSN":["2950-1334"],"issn-type":[{"value":"2950-1334","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The looming threat of invasive fungal infections in heart transplant recipients: Will it be the last of us","name":"articletitle","label":"Article Title"},{"value":"JHLT Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}],"article-number":"100482"}}